The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8822448, 214 ID: ALA3671185
Chembl Id: CHEMBL3671185
PubChem CID: 136618977
Max Phase: Preclinical
Molecular Formula: C30H36N6O2
Molecular Weight: 512.66
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CCN(C(=O)c2cc3c(cc2C)[nH]c(=O)c2cnn(C4CCN(C)CC4)c23)C[C@@H]1c1ccccc1
Standard InChI: InChI=1S/C30H36N6O2/c1-4-34-14-15-35(19-27(34)21-8-6-5-7-9-21)30(38)23-17-24-26(16-20(23)2)32-29(37)25-18-31-36(28(24)25)22-10-12-33(3)13-11-22/h5-9,16-18,22,27H,4,10-15,19H2,1-3H3,(H,32,37)/t27-/m1/s1
Standard InChI Key: DHLRFIVAMVEFBF-HHHXNRCGSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 512.66Molecular Weight (Monoisotopic): 512.2900AlogP: 3.97#Rotatable Bonds: 4Polar Surface Area: 77.47Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.97CX LogP: 2.91CX LogD: 1.17Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.45Np Likeness Score: -1.21
References 1. (2014) Pyrazoloquinoline compound,